Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 24, Issue 15, Pages 831-840
Publisher
Future Medicine Ltd
Online
2023-10-17
DOI
10.2217/pgs-2023-0124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical pharmacogenomics implementation in Thailand: a dream come true
- (2023) Chonlaphat Sukasem et al. PHARMACOGENOMICS
- Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions
- (2022) Beibei Gao et al. BMC Medical Genomics
- Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis
- (2022) Mohitosh Biswas et al. PHARMACOGENOMICS
- Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
- (2022) Mohitosh Biswas et al. CTS-Clinical and Translational Science
- Association of UGT1A1*6 , UGT1A1*28 , or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
- (2022) Chalirmporn Atasilp et al. CTS-Clinical and Translational Science
- Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder
- (2022) Mohitosh Biswas et al. PHARMACOGENOMICS
- Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
- (2022) Napatrupron Koomdee et al. Frontiers in Pharmacology
- Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
- (2022) Mohitosh Biswas et al. Frontiers in Pharmacology
- Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
- (2021) Heshu Abdullah-Koolmees et al. Frontiers in Pharmacology
- Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis
- (2021) Mohitosh Biswas et al. CARDIOVASCULAR DRUGS AND THERAPY
- Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
- (2021) Chonlaphat Sukasem et al. Drug Metabolism and Pharmacokinetics
- Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patients
- (2021) Mohitosh Biswas PHARMACOGENOMICS
- Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis
- (2021) Mohitosh Biswas et al. International Journal of Clinical Pharmacy
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19
- (2021) Mohitosh Biswas et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
- (2021) Chiraphat Kloypan et al. Pharmaceuticals
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
- (2020) David N. Juurlink CANADIAN MEDICAL ASSOCIATION JOURNAL
- Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
- (2020) Fabio S Taccone et al. Lancet Respiratory Medicine
- Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis
- (2020) Mohitosh Biswas et al. PLATELETS
- Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis
- (2020) Mohitosh Biswas et al. Expert Opinion On Drug Safety
- Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications
- (2020) Mohitosh Biswas PHARMACOGENOMICS JOURNAL
- The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
- (2019) Mary V. Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The effect of SNPs in CYP450 in chloroquine/primaquinePlasmodium vivaxmalaria treatment
- (2016) Vinicius A Sortica et al. PHARMACOGENOMICS
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
- (2015) M. Jallouli et al. Arthritis & Rheumatology
- Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
- (2015) Ji Yeon Lee et al. Arthritis & Rheumatology
- Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
- (2014) Kelly Caudle et al. CURRENT DRUG METABOLISM
- Clinical and Pharmacogenetic Influences on Response to Hydroxychloroquine in Discoid Lupus Erythematosus: A Retrospective Cohort Study
- (2011) Shyamal Wahie et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started